References
- Kelley WN, Wortmann RL. Gout and hyperuricemia. In: Kelley WN, Ruddy S, Harris ED Jr, et al, eds. Textbook of rheumatology. 5th ed. Philadelphia: Saunders, 1997: 1313–51
- Yu TF. Diversity of clinical features in gouty arthritis. Semin Arthritis Rheum 1984; 13(4): 360–8
- Puig JG, Michan AD, Jimenez ML, et al. Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 1991; 151(4): 726–32
- Lally EV, Ho G Jr, Kaplan SR. The clinical spectrum of gouty arthritis in women. Arch Intern Med 1986; 146(11): 2221–5
- Gerster JC, Landry M, Duvoisin B, et al. Computed tomography of the knee joint as an indicator of intraarticular tophi in gout. Arthritis Rheum 1996; 39(8): 1406–9
- Popp JD, Bidgood WD Jr, Edwards NL. Magnetic resonance imaging of tophaceous gout in the hands and wrists. Semin Arthritis Rheum 1996; 25(4): 282–9
- McCarty DJ. Gout without hyperuricemia. JAMA 1994; 271(4): 302–3
- McCarthy GM, Barthelemy CR, Veum JA, et al. Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout. Arthritis Rheum 1991; 34(12): 1489–94
- Zonana-Nacach A, Alarcon GS, Daniel WW. Rheumatoid arthritis preceding the onset of polyarticular tophaceous gout. (Letter) Ann Rheum Dis 1996; 55(7): 489–90
- Uri DS, Martel W. Radiologic manifestations of the crystal-related arthropathies. Semin Roentgenol 1996; 31(3): 229–38
- Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin North Am 1988; 14(2): 441–57
- Emmerson BT. The management of gout. N Engl J Med 1996; 334(7): 445–51
- Schumacher HR, Alvarez MJ. Clues to common crystal induced arthropathies. IM 1993 Dec; 35–47
- Ferraz MB, O'Brien B. A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis. J Rheumatol 1995; 22(5): 908–14
- Rosenthal AK, Ryan LM. Treatment of refractory crystal-associated arthritis. Rheum Dis Clin North Am 1995; 21(1): 151–6